Skip to main content
Log in

Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy

A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study

  • Original Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

The syndrome of heart failure (HF) is characterized by left ventricular dysfunction and a compensatory chronic over activation of the sympathetic nervous system. We wanted to investigate if the beneficial effects of exercise training (ET) in HF patients on optimal medical therapy (OMT) are associated with alterations in cardiac sympathetic activity.

Methods

Cardiac sympathetic activity was evaluated at baseline and after 12 weeks using metaiodobenzylguanidine scintigraphy in 23 patients with stable HF participating in the SmartEx trial. Patients with HF in New York Heart Association class II or III and left ventricular ejection fraction <35 % were randomized to three different ET groups.

Results

We found no statistically significant changes in cardiac sympathetic activity after 12 weeks of ET. Heart to mediastinum (H/M) ratio at 15 minutes (0.00174 ± 0.0841, P = 0.922), H/M ratio at 4 hours (−0.00565 ± 0.1163, P = 0.818) and washout ratio (WR) (−1.2666 ± 16.5412, P = 0.717). A further group-wise analysis of the three ET groups did not show any difference between the groups.

Conclusion

A 12-week ET program did not alter the abnormal cardiac sympathetic activity in stable HF patients on modern OMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Abbreviations

HF:

Heart failure

ET:

Exercise training

MIBG:

Iodine-123-metaiodobenzylguanidine

H/M:

Heart to mediastinum ratio

WR:

Washout ratio

LVEF:

Left ventricle ejection fraction

NE:

Norepinephrine

VO2peak :

Peak oxygen uptake

OMT:

Optimal medical therapy

References

  1. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615–21. doi:10.1161/01.cir.73.4.615.

    Article  PubMed  CAS  Google Scholar 

  2. Caldwell JH, Caldwell JH, Link JM, et al. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med. 2008;49:234–41. doi:10.2967/jnumed.107.044339.

    Article  PubMed  Google Scholar 

  3. Ungerer M, Böhm M, Elce JS, et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454–63. doi:10.1161/01.cir.87.2.454.

    Article  PubMed  CAS  Google Scholar 

  4. Cohen-Solal A, Esanu Y, Logeart D, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol. 1999;33:759–66. doi:10.1016/S0735-1097(98)00608-1.

    Article  PubMed  CAS  Google Scholar 

  5. Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol. 2010;55:2212–21. doi:10.1016/j.jacc.2010.01.014.

    Article  PubMed  Google Scholar 

  6. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471–7.

    PubMed  CAS  Google Scholar 

  7. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation. 1988;78:516–21. doi:10.1161/01.cir.78.3.516.

    Article  PubMed  CAS  Google Scholar 

  8. Sato M, Maehara K, Yaoita H, et al. Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure. J Nucl Med. 2003;44:1618–24.

    PubMed  CAS  Google Scholar 

  9. Agostini D, Lecluse E, Belin A, et al. Impact of exercise rehabilitation on cardiac neuronal function in heart failure: An iodine-123 metaiodobenzylguanidine scintigraphy study. Eur J Nucl Med. 1998;25:235–41. doi:10.1007/s002590050222.

    Article  PubMed  CAS  Google Scholar 

  10. Schofer J, Spielmann R, Schuchert A, et al. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988;12:1252–8. doi:10.1016/0735-1097(88)92608-3.

    Article  PubMed  CAS  Google Scholar 

  11. Chizzola PR, Gonçalves de Freitas HF, Marinho NVS, et al. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol. 2006;106:29–34. doi:10.1016/j.ijcard.2004.12.050.

    Article  PubMed  Google Scholar 

  12. McMurray JJV, Adamopoulos S, Anker A-BSD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69. doi:10.1093/eurjhf/hfs105.

    Article  PubMed  CAS  Google Scholar 

  13. Stoylen A, Conraads VM, Halle M, et al. Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF-rationale and design. Eur J Prev Cardiol. 2012;19:813–21. doi:10.1177/1741826711403252.

    Article  PubMed  Google Scholar 

  14. Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: The benefit depends on the type of training performed. J Am Coll Cardiol. 2007;49:2329–36. doi:10.1016/j.jacc.2007.02.055.

    Article  PubMed  Google Scholar 

  15. Veltman CE, Boogers MJ, Meinardi JE, et al. Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599–608. doi:10.1007/s00259-012-2180-2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol. 2008;16:113–21. doi:10.1007/s12350-008-9008-2.

    Article  Google Scholar 

  17. Murad K, Brubaker PH, Fitzgerald DM, et al. Exercise training improves heart rate variability in older patients with heart failure: A randomized, controlled, single-blinded trial. Congest Heart Fail. 2012;18:192–7. doi:10.1111/j.1751-7133.2011.00282.x.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Munk PS, Butt N, Larsen AI. High-intensity interval exercise training improves heart rate variability in patients following percutaneous coronary intervention for angina pectoris. Int J Cardiol. 2010;145:312–4. doi:10.1016/j.ijcard.2009.11.015.

    Article  PubMed  Google Scholar 

  19. Larsen AI, Gjesdal K, Hall C, Aukrust PP. Effect of exercise training in patients with heart failure: A pilot study on autonomic balance assessed by heart rate variability. Eur J Prev Cardiol. 2004;11:162–7. doi:10.1097/01.hjr.0000124214.21584.bb.

    Article  Google Scholar 

  20. Agostini D, Belin A, Amar MH, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: A 123I-MIBG scintigraphic study. J Nucl Med. 2000;41:845–51.

    PubMed  CAS  Google Scholar 

  21. Cohen-Solal A, Rouzet F, Berdeaux A, et al. Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med Off Publ Soc Nucl Med. 2005;46:1796–803.

    CAS  Google Scholar 

  22. Takeishi Y, Atsumi H, Fujiwara S, et al. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med Off Publ Soc Nucl Med. 1997;38:1085–9.

    CAS  Google Scholar 

  23. Kasama S, Toyama T, Kumakura H, et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003;41:574–81. doi:10.1016/s0735-1097(02)02855-3.

    Article  PubMed  CAS  Google Scholar 

  24. Floras JS, Ponikowski P. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J. 2015;36:1974–82. doi:10.1093/eurheartj/ehv087.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Gao J, Zucker IH, Gao L. Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure. Am J Hypertens. 2014;27:1248–56. doi:10.1093/ajh/hpu044.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Verberne HJ, Verberne HJ, Brewster LM, et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J. 2008;29:1147–59. doi:10.1093/eurheartj/ehn113.

    Article  PubMed  Google Scholar 

  27. McMurray JJV, Adamopoulos S, Anker A-BSD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847. doi:10.1093/eurheartj/ehs104.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Stavanger Health Research: Åse Marit Brøndbo, Anne Haugland, and Marit Kristiansen for their help and contributions during exercise training. Jorunn Nilsen for coordinating, testing, and helping with examinations. Torbjørn Aarsland for CPET examinations. The staff at the Department of Nuclear Imaging, Stavanger University Hospital: Randi Ursin, Jan Erik Berge, Azora Marie Ramsvik, and Hilde Ødegård. Stavanger University: Jan Terje Kvaløy and Lena Bache-Mathiesen for statistical advice. Camilla Normand for linguistic advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Torstein Valborgland MD.

Ethics declarations

Disclosure

Torstein Valborgland, Kjetil Isaksen, Peter Scott Munk, Zbigniew Piotr Grabowski and Alf Inge Larsen have no conflict of interest.

Additional information

Clinical trial registration information: a sub study of the SmartEx trial: Clinical trials.gov NCT00917046, https://clinicaltrials.gov/ct2/show/NCT00917046

Funding: This work was supported by Western Norway Regional Health Authority [Grant Number 911 715].

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valborgland, T., Isaksen, K., Munk, P.S. et al. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy. J. Nucl. Cardiol. 25, 1164–1171 (2018). https://doi.org/10.1007/s12350-016-0724-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-016-0724-8

Key Words

Navigation